Influence of trial duration on the bias of the estimated treatment effect in clinical trials when individual heterogeneity is ignored
From MaRDI portal
Publication:5257926
DOI10.1002/bimj.201400046zbMath1325.62195OpenAlexW1948419113WikidataQ41568232 ScholiaQ41568232MaRDI QIDQ5257926
Elsa Cécilia-Joseph, Bertran Auvert, Thierry Moreau, Philippe Broët
Publication date: 24 June 2015
Published in: Biometrical Journal (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1002/bimj.201400046
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical epidemiology (92C60)
Related Items (1)
Uses Software
Cites Work
- Unnamed Item
- On proportional hazards assumption under the random effects models
- Survival and event history analysis. A process point of view
- Maximum penalized likelihood estimation in a Gamma-frailty model
- Analysis of multivariate survival data
- Robust inference for univariate proportional hazards frailty regression models
- The unobserved heterogeneity distribution in duration analysis
- Biased estimates of treatment effect in randomized experiments with nonlinear regressions and omitted covariates
- Misspecified proportional hazard models
- Effect of Frailty on Marginal Regression Estimates in Survival Analysis
- Estimation of Variance in Cox's Regression Model with Shared Gamma Frailties
- Assessing the Sensitivity of Regression Results to Unmeasured Confounders in Observational Studies
- Bias and Sensitivity Analysis When Estimating Treatment Effects from the Cox Model with Omitted Covariates
- Estimating average regression effect under non-proportional hazards
This page was built for publication: Influence of trial duration on the bias of the estimated treatment effect in clinical trials when individual heterogeneity is ignored